MAXCYTE INC. - COMMON
3.8800
08-October-24 15:59:58
15 minutes delayed
Stocks
+0.1000
+2.65%
Today's range
3.7500 - 3.8900
ISIN
N/A
Source
NASDAQ
-
MaxCyte Reports Third Quarter 2022 Financial Results
09 Nov 2022 16:05:03 By Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
02 Nov 2022 08:05:00 By Nasdaq GlobeNewswire
-
MaxCyte to Report Third Quarter 2022 Financial Results on November 9, 2022
12 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
28 Sep 2022 08:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Debuts New State-of-the-Art Headquarters in Maryland’s I-270 Biotech Corridor
21 Sep 2022 08:05:00 By Nasdaq GlobeNewswire
-
MaxCyte to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
07 Sep 2022 16:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Reports Second Quarter and Half-Year 2022 Financial Results
10 Aug 2022 16:05:01 By Nasdaq GlobeNewswire
-
MaxCyte to Report Second Quarter 2022 Financial Results on August 10, 2022
15 Jul 2022 08:00:00 By Nasdaq GlobeNewswire
-
MaxCyte Signs Strategic Platform License with LG Chem to Advance its Allogeneic CAR-T Programs
12 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 May 2022 16:30:00 By Nasdaq GlobeNewswire
-
MaxCyte Reports First Quarter Financial Results
09 May 2022 16:05:03 By Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
03 May 2022 16:05:01 By Nasdaq GlobeNewswire
-
MaxCyte to Report First Quarter 2022 Financial Results on May 9, 2022
20 Apr 2022 16:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 Apr 2022 09:00:00 By Nasdaq GlobeNewswire
-
12 Apr 2022 16:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Reports Fourth Quarter and Full Year Financial Results
22 Mar 2022 16:05:01 By Nasdaq GlobeNewswire
-
MaxCyte, Inc. Names Cenk Sumen Chief Scientific Officer
09 Mar 2022 16:15:00 By Nasdaq GlobeNewswire
-
MaxCyte to Report Fourth Quarter and Full Year 2021 Financial Results on March 22, 2022
24 Feb 2022 08:00:01 By Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
14 Feb 2022 08:00:01 By Nasdaq GlobeNewswire
-
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 Feb 2022 17:00:00 By Nasdaq GlobeNewswire